Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Thioredoxin-A is a virulence factor and mediator of the type IV pilus system in Acinetobacter baumannii.

May HC, Yu JJ, Zhang H, Wang Y, Cap AP, Chambers JP, Guentzel MN, Arulanandam BP.

PLoS One. 2019 Jul 2;14(7):e0218505. doi: 10.1371/journal.pone.0218505. eCollection 2019.

2.

Acinetobacter baumannii Gastrointestinal Colonization Is Facilitated by Secretory IgA Which Is Reductively Dissociated by Bacterial Thioredoxin A.

Ketter PM, Yu JJ, Guentzel MN, May HC, Gupta R, Eppinger M, Klose KE, Seshu J, Chambers JP, Cap AP, Arulanandam BP.

MBio. 2018 Jul 10;9(4). pii: e01298-18. doi: 10.1128/mBio.01298-18.

3.

Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System.

May HC, Yu JJ, Guentzel MN, Chambers JP, Cap AP, Arulanandam BP.

Front Microbiol. 2018 Mar 5;9:336. doi: 10.3389/fmicb.2018.00336. eCollection 2018. Review.

4.

Microbial co-infection alters macrophage polarization, phagosomal escape, and microbial killing.

Trivedi NH, Yu JJ, Hung CY, Doelger RP, Navara CS, Armitige LY, Seshu J, Sinai AP, Chambers JP, Guentzel MN, Arulanandam BP.

Innate Immun. 2018 Apr;24(3):152-162. doi: 10.1177/1753425918760180. Epub 2018 Feb 26.

PMID:
29482417
5.

Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.

Ainsworth S, Ketter PM, Yu JJ, Grimm RC, May HC, Cap AP, Chambers JP, Guentzel MN, Arulanandam BP.

Vaccine. 2017 Jun 8;35(26):3387-3394. doi: 10.1016/j.vaccine.2017.05.017. Epub 2017 May 15.

6.

Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigs.

Wali S, Gupta R, Yu JJ, Lanka GKK, Chambers JP, Guentzel MN, Zhong G, Murthy AK, Arulanandam BP.

Immunol Cell Biol. 2017 May;95(5):454-460. doi: 10.1038/icb.2016.122. Epub 2016 Dec 19.

7.

Guinea pig genital tract lipidome reveals in vivo and in vitro regulation of phosphatidylcholine 16:0/18:1 and contribution to Chlamydia trachomatis serovar D infectivity.

Wali S, Gupta R, Yu JJ, Mfuh A, Gao X, Guentzel MN, Chambers JP, Abu Bakar S, Zhong G, Arulanandam BP.

Metabolomics. 2016 Apr;12(4). pii: 74. Epub 2016 Mar 8.

8.

Antigen specific immune response in Chlamydia muridarum genital infection is dependent on murine microRNAs-155 and -182.

Gupta R, Arkatkar T, Keck J, Koundinya GK, Castillo K, Hobel S, Chambers JP, Yu JJ, Guentzel MN, Aigner A, Christenson LK, Arulanandam BP.

Oncotarget. 2016 Oct 4;7(40):64726-64742. doi: 10.18632/oncotarget.11461.

9.

Contribution of FcɛRI-associated vesicles to mast cell-macrophage communication following Francisella tularensis infection.

Rodriguez AR, Yu JJ, Navara C, Chambers JP, Guentzel MN, Arulanandam BP.

Innate Immun. 2016 Oct;22(7):567-74. doi: 10.1177/1753425916663639. Epub 2016 Aug 22.

PMID:
27554051
10.

M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensis.

Cunningham AL, Guentzel MN, Yu JJ, Hung CY, Forsthuber TG, Navara CS, Yagita H, Williams IR, Klose KE, Eaves-Pyles TD, Arulanandam BP.

PLoS One. 2016 Apr 21;11(4):e0153402. doi: 10.1371/journal.pone.0153402. eCollection 2016.

11.

IgA modulates respiratory dysfunction as a sequela to pulmonary chlamydial infection as neonates.

Lanka GK, Yu JJ, Gong S, Gupta R, Mustafa SB, Murthy AK, Zhong G, Chambers JP, Guentzel MN, Arulanandam BP.

Pathog Dis. 2016 Apr;74(3). pii: ftv121. doi: 10.1093/femspd/ftv121. Epub 2016 Jan 10.

12.

Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE.

Ji N, Kovalovsky A, Fingerle-Rowson G, Guentzel MN, Forsthuber TG.

Neurol Neuroimmunol Neuroinflamm. 2015 Aug 6;2(5):e139. doi: 10.1212/NXI.0000000000000139. eCollection 2015 Oct.

13.

Chlamydia pneumoniae promotes dysfunction of pancreatic beta cells.

Rodriguez AR, Plascencia-Villa G, Witt CM, Yu JJ, José-Yacamán M, Chambers JP, Perry G, Guentzel MN, Arulanandam BP.

Cell Immunol. 2015 Jun;295(2):83-91. doi: 10.1016/j.cellimm.2015.03.010. Epub 2015 Apr 1.

14.

Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs.

Wali S, Gupta R, Veselenak RL, Li Y, Yu JJ, Murthy AK, Cap AP, Guentzel MN, Chambers JP, Zhong G, Rank RG, Pyles RB, Arulanandam BP.

PLoS One. 2014 Dec 11;9(12):e114261. doi: 10.1371/journal.pone.0114261. eCollection 2014.

15.

Reply to letter to the editor RE: "in vivo whole animal body imaging reveals colonization of Chlamydia muridarum to the lower genital tract at early stages of infection".

Gupta R, Guentzel MN, Arulanandam BP.

Mol Imaging Biol. 2014 Oct;16(5):606-7. doi: 10.1007/s11307-014-0778-4. No abstract available.

PMID:
25082537
16.

Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112ΔiglB::fljB.

Cunningham AL, Dang KM, Yu JJ, Guentzel MN, Heidner HW, Klose KE, Arulanandam BP.

Vaccine. 2014 Sep 8;32(40):5234-40. doi: 10.1016/j.vaccine.2014.07.038. Epub 2014 Jul 19.

17.

Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.

Ketter PM, Guentzel MN, Schaffer B, Herzig M, Wu X, Montgomery RK, Parida BK, Fedyk CG, Yu JJ, Jorgensen J, Chambers JP, Cap AP, Arulanandam BP.

Infect Immun. 2014 Sep;82(9):3910-8. doi: 10.1128/IAI.01958-14. Epub 2014 Jul 7.

18.

Chlamydia muridarum infection associated host MicroRNAs in the murine genital tract and contribution to generation of host immune response.

Gupta R, Arkatkar T, Yu JJ, Wali S, Haskins WE, Chambers JP, Murthy AK, Bakar SA, Guentzel MN, Arulanandam BP.

Am J Reprod Immunol. 2015 Feb;73(2):126-40. doi: 10.1111/aji.12281. Epub 2014 Jun 28.

19.

In vivo whole animal body imaging reveals colonization of Chlamydia muridarum to the lower genital tract at early stages of infection.

Gupta R, Wali S, Yu JJ, Chambers JP, Zhong G, Murthy AK, Bakar SA, Guentzel MN, Arulanandam BP.

Mol Imaging Biol. 2014 Oct;16(5):635-41. doi: 10.1007/s11307-014-0732-5.

PMID:
24723309
20.

Genome Sequences of Four Acinetobacter baumannii-A. calcoaceticus Complex Isolates from Combat-Related Infections Sustained in the Middle East.

Ketter P, Guentzel MN, Chambers JP, Jorgensen J, Murray CK, Cap AP, Yu JJ, Eppinger M, Arulanandam BP.

Genome Announc. 2014 Feb 6;2(1). pii: e00026-14. doi: 10.1128/genomeA.00026-14.

21.

A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.

Li W, Murthy AK, Lanka GK, Chetty SL, Yu JJ, Chambers JP, Zhong G, Forsthuber TG, Guentzel MN, Arulanandam BP.

Vaccine. 2013 Nov 19;31(48):5722-8. doi: 10.1016/j.vaccine.2013.09.036. Epub 2013 Oct 1.

22.

Vaginal chlamydial clearance following primary or secondary infection in mice occurs independently of TNF-α.

Kamalakaran S, Chaganty BK, Gupta R, Guentzel MN, Chambers JP, Murthy AK, Arulanandam BP.

Front Cell Infect Microbiol. 2013 Mar 11;3:11. doi: 10.3389/fcimb.2013.00011. eCollection 2013.

23.

Mast cells: multitalented facilitators of protection against bacterial pathogens.

Trivedi NH, Guentzel MN, Rodriguez AR, Yu JJ, Forsthuber TG, Arulanandam BP.

Expert Rev Clin Immunol. 2013 Feb;9(2):129-38. doi: 10.1586/eci.12.95. Review.

24.

Mucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model.

Signarovitz AL, Ray HJ, Yu JJ, Guentzel MN, Chambers JP, Klose KE, Arulanandam BP.

PLoS One. 2012;7(10):e47639. doi: 10.1371/journal.pone.0047639. Epub 2012 Oct 30.

25.

Comparison of bone marrow-derived and mucosal mast cells in controlling intramacrophage Francisella tularensis replication.

Hunter C, Rodriguez A, Yu JJ, Chambers J, Guentzel MN, Arulanandam B.

Exp Biol Med (Maywood). 2012 Jun;237(6):617-21. doi: 10.1258/ebm.2012.011389. Epub 2012 Jun 11.

26.

Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensis.

Rodriguez AR, Yu JJ, Guentzel MN, Navara CS, Klose KE, Forsthuber TG, Chambers JP, Berton MT, Arulanandam BP.

J Immunol. 2012 Jun 1;188(11):5604-11. doi: 10.4049/jimmunol.1200039. Epub 2012 Apr 23.

27.

Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.

Sanapala S, Yu JJ, Murthy AK, Li W, Guentzel MN, Chambers JP, Klose KE, Arulanandam BP.

Infect Immun. 2012 Jun;80(6):2177-85. doi: 10.1128/IAI.00036-12. Epub 2012 Apr 9.

28.

Neonatal chlamydial pneumonia induces altered respiratory structure and function lasting into adult life.

Jupelli M, Murthy AK, Chaganty BK, Guentzel MN, Selby DM, Vasquez MM, Mustafa SB, Henson BM, Seidner SR, Zhong G, Arulanandam BP.

Lab Invest. 2011 Oct;91(10):1530-9. doi: 10.1038/labinvest.2011.103. Epub 2011 Jul 18.

29.

Non-FcεR bearing mast cells secrete sufficient interleukin-4 to control Francisella tularensis replication within macrophages.

Thathiah P, Sanapala S, Rodriguez AR, Yu JJ, Murthy AK, Guentzel MN, Forsthuber TG, Chambers JP, Arulanandam BP.

Cytokine. 2011 Aug;55(2):211-20. doi: 10.1016/j.cyto.2011.04.009. Epub 2011 May 12.

30.

Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection.

Murthy AK, Li W, Chaganty BK, Kamalakaran S, Guentzel MN, Seshu J, Forsthuber TG, Zhong G, Arulanandam BP.

Infect Immun. 2011 Jul;79(7):2928-35. doi: 10.1128/IAI.05022-11. Epub 2011 May 2.

31.

Effects of bacterial microflora of the lower digestive tract of free-range waterfowl on influenza virus activation.

King MD, Guentzel MN, Arulanandam BP, Bodour AA, Brahmakshatriya V, Lupiani B, Chambers JP.

Appl Environ Microbiol. 2011 Jun;77(12):4119-25. doi: 10.1128/AEM.02578-10. Epub 2011 Apr 29.

32.

Evasion of IFN-γ signaling by Francisella novicida is dependent upon Francisella outer membrane protein C.

Nallaparaju KC, Yu JJ, Rodriguez SA, Zogaj X, Manam S, Guentzel MN, Seshu J, Murthy AK, Chambers JP, Klose KE, Arulanandam BP.

PLoS One. 2011 Mar 31;6(3):e18201. doi: 10.1371/journal.pone.0018201.

33.

Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus.

Guentzel MN.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 26.

34.

Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation.

Murthy AK, Chaganty BK, Troutman T, Guentzel MN, Yu JJ, Ali SK, Lauriano CM, Chambers JP, Klose KE, Arulanandam BP.

PLoS One. 2011 Feb 9;6(2):e16847. doi: 10.1371/journal.pone.0016847.

35.

Vaccination with the defined chlamydial secreted protein CPAF induces robust protection against female infertility following repeated genital chlamydial challenge.

Murthy AK, Li W, Guentzel MN, Zhong G, Arulanandam BP.

Vaccine. 2011 Mar 21;29(14):2519-22. doi: 10.1016/j.vaccine.2011.01.074. Epub 2011 Feb 5.

36.

Immunization with dendritic cells pulsed ex vivo with recombinant chlamydial protease-like activity factor induces protective immunity against genital chlamydiamuridarum challenge.

Li W, Murthy AK, Chaganty BK, Guentzel MN, Seshu J, Chambers JP, Zhong G, Arulanandam BP.

Front Immunol. 2011 Dec 8;2:73. doi: 10.3389/fimmu.2011.00073. eCollection 2011.

37.

Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification.

Rodriguez AR, Yu JJ, Murthy AK, Guentzel MN, Klose KE, Forsthuber TG, Chambers JP, Berton MT, Arulanandam BP.

Mucosal Immunol. 2011 Mar;4(2):217-26. doi: 10.1038/mi.2010.59. Epub 2010 Sep 22.

38.

Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.

Li W, Murthy AK, Guentzel MN, Chambers JP, Forsthuber TG, Seshu J, Zhong G, Arulanandam BP.

Infect Immun. 2010 Sep;78(9):3942-9. doi: 10.1128/IAI.00346-10. Epub 2010 Jul 6.

39.

The Fischer 344 rat reflects human susceptibility to francisella pulmonary challenge and provides a new platform for virulence and protection studies.

Ray HJ, Chu P, Wu TH, Lyons CR, Murthy AK, Guentzel MN, Klose KE, Arulanandam BP.

PLoS One. 2010 Apr 1;5(4):e9952. doi: 10.1371/journal.pone.0009952.

40.

The contribution of interleukin-12/interferon-gamma axis in protection against neonatal pulmonary Chlamydia muridarum challenge.

Jupelli M, Selby DM, Guentzel MN, Chambers JP, Forsthuber TG, Zhong G, Murthy AK, Arulanandam BP.

J Interferon Cytokine Res. 2010 Jun;30(6):407-15. doi: 10.1089/jir.2009.0083.

41.

Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge.

Chaganty BK, Murthy AK, Evani SJ, Li W, Guentzel MN, Chambers JP, Zhong G, Arulanandam BP.

Vaccine. 2010 Mar 8;28(11):2323-9. doi: 10.1016/j.vaccine.2009.12.064. Epub 2010 Jan 5.

42.

Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.

Yu JJ, Goluguri T, Guentzel MN, Chambers JP, Murthy AK, Klose KE, Forsthuber TG, Arulanandam BP.

Clin Vaccine Immunol. 2010 Feb;17(2):215-22. doi: 10.1128/CVI.00361-09. Epub 2009 Dec 16.

43.

Chlamydial protease-like activity factor--insights into immunity and vaccine development.

Murthy AK, Guentzel MN, Zhong G, Arulanandam BP.

J Reprod Immunol. 2009 Dec;83(1-2):179-84. doi: 10.1016/j.jri.2009.05.007. Epub 2009 Oct 23. Review.

44.

Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.

Cong Y, Yu JJ, Guentzel MN, Berton MT, Seshu J, Klose KE, Arulanandam BP.

Vaccine. 2009 Sep 18;27(41):5554-61. doi: 10.1016/j.vaccine.2009.07.034. Epub 2009 Aug 3.

45.

Proteolytic bacteria in the lower digestive tract of poultry may affect avian influenza virus pathogenicity.

King MD, Guentzel MN, Arulanandam BP, Lupiani B, Chambers JP.

Poult Sci. 2009 Jul;88(7):1388-93. doi: 10.3382/ps.2008-00549.

PMID:
19531708
46.

A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge.

Murthy AK, Chaganty BK, Li W, Guentzel MN, Chambers JP, Seshu J, Zhong G, Arulanandam BP.

FEMS Immunol Med Microbiol. 2009 Mar;55(2):271-9. doi: 10.1111/j.1574-695X.2008.00517.x.

47.

Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.

Ray HJ, Cong Y, Murthy AK, Selby DM, Klose KE, Barker JR, Guentzel MN, Arulanandam BP.

Clin Vaccine Immunol. 2009 Apr;16(4):444-52. doi: 10.1128/CVI.00405-08. Epub 2009 Feb 11.

48.

Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4.

Ketavarapu JM, Rodriguez AR, Yu JJ, Cong Y, Murthy AK, Forsthuber TG, Guentzel MN, Klose KE, Berton MT, Arulanandam BP.

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9313-8. doi: 10.1073/pnas.0707636105. Epub 2008 Jun 30.

49.

CD4+ T cells are required during priming but not the effector phase of antibody-mediated IFN-gamma-dependent protective immunity against pulmonary Francisella novicida infection.

Powell HJ, Cong Y, Yu JJ, Guentzel MN, Berton MT, Klose KE, Murthy AK, Arulanandam BP.

Immunol Cell Biol. 2008 Aug-Sep;86(6):515-22. doi: 10.1038/icb.2008.31. Epub 2008 Apr 22.

PMID:
18427567
50.

Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice.

Jupelli M, Guentzel MN, Meier PA, Zhong G, Murthy AK, Arulanandam BP.

J Immunol. 2008 Mar 15;180(6):4148-55.

Supplemental Content

Loading ...
Support Center